US 6310064
Aralkyl diazabicycloalkane derivatives for CNS disorders
expired A61KA61K31/495A61P
Quick answer
US patent 6310064 (Aralkyl diazabicycloalkane derivatives for CNS disorders) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/495, A61P, A61P25/18